SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.277
AS - Asia 10.539
EU - Europa 5.141
SA - Sud America 1.738
AF - Africa 233
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 39.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.932
SG - Singapore 4.008
CN - Cina 2.578
BR - Brasile 1.353
VN - Vietnam 1.194
UA - Ucraina 1.037
HK - Hong Kong 973
DE - Germania 821
IT - Italia 697
TR - Turchia 664
GB - Regno Unito 575
PL - Polonia 414
FI - Finlandia 360
FR - Francia 338
SE - Svezia 275
RU - Federazione Russa 269
IN - India 219
JP - Giappone 191
MX - Messico 156
AR - Argentina 143
BD - Bangladesh 140
ID - Indonesia 140
CA - Canada 137
NL - Olanda 81
ZA - Sudafrica 70
IQ - Iraq 68
PK - Pakistan 65
ES - Italia 63
EC - Ecuador 57
CO - Colombia 50
AT - Austria 46
UZ - Uzbekistan 41
VE - Venezuela 41
SA - Arabia Saudita 38
BE - Belgio 34
MA - Marocco 31
PH - Filippine 31
CL - Cile 28
TN - Tunisia 28
MY - Malesia 23
EG - Egitto 22
IR - Iran 22
LT - Lituania 20
KE - Kenya 19
KR - Corea 19
BO - Bolivia 17
PY - Paraguay 17
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CZ - Repubblica Ceca 15
ET - Etiopia 14
CH - Svizzera 13
NP - Nepal 13
DZ - Algeria 12
PE - Perù 12
JM - Giamaica 11
IL - Israele 10
JO - Giordania 10
RO - Romania 10
AL - Albania 9
GR - Grecia 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
HN - Honduras 8
TH - Thailandia 8
CR - Costa Rica 7
IE - Irlanda 7
KZ - Kazakistan 7
LY - Libia 7
PS - Palestinian Territory 7
PT - Portogallo 7
OM - Oman 6
RS - Serbia 6
BG - Bulgaria 5
HU - Ungheria 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EU - Europa 4
MD - Moldavia 4
MN - Mongolia 4
QA - Qatar 4
SN - Senegal 4
AO - Angola 3
BF - Burkina Faso 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
KW - Kuwait 3
LV - Lettonia 3
MU - Mauritius 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
Totale 39.906
Salva come PNG Salva come JPEG
Città #
Fairfield 2.681
Singapore 2.535
Woodbridge 2.480
Ashburn 2.383
Houston 1.580
Jacksonville 1.139
Seattle 1.060
Chandler 993
Hong Kong 961
San Jose 903
Ann Arbor 893
Wilmington 879
Cambridge 859
Beijing 713
Santa Clara 707
Izmir 415
Warsaw 402
Ho Chi Minh City 360
Nanjing 335
Los Angeles 301
Hanoi 255
Princeton 251
Dallas 241
San Diego 234
Lauterbourg 204
Boardman 194
Tokyo 183
New York 170
Ferrara 154
Munich 142
Milan 131
Addison 121
São Paulo 105
Helsinki 101
Dong Ket 96
Shanghai 96
Nanchang 94
Mexico City 92
Shenyang 92
Jakarta 89
Hefei 82
Orem 81
Dearborn 76
Hebei 68
Tianjin 68
Atlanta 67
Chicago 65
London 64
Council Bluffs 61
Mountain View 59
Jinan 57
Bremen 55
Da Nang 55
Jiaxing 53
Brooklyn 52
The Dalles 48
Montreal 46
Changsha 44
Haiphong 44
Kunming 43
Rio de Janeiro 42
Turku 42
Buffalo 41
Denver 41
Johannesburg 41
Chennai 40
Falls Church 40
Moscow 40
Hangzhou 39
Redwood City 39
San Francisco 38
Columbus 36
Frankfurt am Main 36
Norwalk 36
San Mateo 36
Tashkent 36
Manchester 35
Toronto 35
Falkenstein 34
Guangzhou 34
Zhengzhou 33
Nuremberg 32
Stockholm 32
Brussels 31
Mumbai 31
Boston 29
Rome 29
Amsterdam 28
Hải Dương 28
Poplar 28
Tappahannock 28
Brasília 27
Orange 27
Phoenix 27
Belo Horizonte 26
Des Moines 26
Ningbo 26
Verona 24
Auburn Hills 23
Quito 23
Totale 28.131
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 346
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 297
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 296
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 281
Loss of miR-204 expression is a key event in melanoma 280
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 272
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 268
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 262
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 262
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 253
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 252
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 249
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 247
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 246
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 246
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 243
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 243
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 242
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 237
Identification of microRNA activity by Targets' Reverse EXpression. 234
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 233
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 229
MicroRNA e cancro 229
A microRNA DNA methylation signature for human cancer metastasis 228
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 226
MicroRNA involvement in hepatocellular carcinoma 223
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 223
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 222
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 220
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 218
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 217
Reprogramming of miRNA networks in cancer and leukemia 215
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 215
A microRNA signature of hypoxia 214
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 214
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 213
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 212
MicroRNA expression profiling in human Barrett's carcinogenesis. 212
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 212
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 211
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 210
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 206
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 206
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 204
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 204
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 204
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 204
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 203
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 202
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 202
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 200
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 199
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 199
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 198
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 196
Espressione dei MicroRNA nei carcinomi mammari 196
Aberrant FHIT transcripts in Merkel cell carcinoma 194
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 194
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 192
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 191
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 190
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 190
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 189
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 189
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 189
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 188
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 186
Knockout mice reveal a tumor suppressor function for Testin 185
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 185
Tumor suppressor functions of ARLTS1 in lung cancers 185
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 185
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 184
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 183
Extensive modulation of a set of microRNAs in primary glioblastoma 182
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 182
Mutated beta-catenin evades a microRNA-dependent regulatory loop 182
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 181
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 180
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 180
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 179
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 179
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 177
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 177
The role of microRNA genes in papillary thyroid carcinoma 177
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 177
MicroRNA deregulation in human thyroid papillary carcinomas 176
Alternative splicing, genomic structure, and fine chromosome localization of REV3L 174
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 174
MicroRNA profiles discriminate among colon cancer metastasis 172
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 171
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 170
MicroRNA-133 controls cardiac hypertrophy 169
MicroRNA genes are frequently located near mouse cancer susceptibility loci 169
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 169
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 169
Oncogenic role of miR-483-3p at the IGF2/483 locus 168
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 167
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 167
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 167
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 166
Totale 20.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.415
Totale 169.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.085 0 0 0 0 0 0 0 0 0 406 401 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/202612.873 1.194 650 1.219 1.860 1.889 828 1.714 812 1.523 1.184 0 0
Totale 40.276